The immune dysregulation triggered by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been hypothesized as a causal pathway for the increasingly reported oral manifestations associated with coronavirus diseases (COVID-19), especially the ones of fungal origin. [1][2][3] As a result of this, we aim to report according to the CARE guidelines, three COVID-19 cases who sought teleconsultations from our private practice (Cairo, Egypt) from July to September 2020. In addition, we have performed a literature search in Ovid MEDLINE®, EMBASE, Cochrane Library, and Epistemonikos from inception until November 30, 2020, with a combination of keywords (COVID-19 or SARS-CoV-2) and oral candidiasis.
Objectives This pilot survey aims to study the oral manifestations associated with COVID‐19 infection and report the prevalence of oral signs and symptoms in COVID‐19 patients. Materials and Methods From May 15 to June 10, 2020, we used an online questionnaire containing the oral manifestations that are expected to be associated with the COVID‐19 infection. Adults in our survey who have been diagnosed with COVID‐19 positive were confirmed with reverse transcriptase PCR (RT‐PCR), and isolated in various hospitals in Cairo, Egypt. Results This pilot study included 58 (53.4% males and 46.6% females) COVID‐19 patients ages 18–46 years, and 13 (22.4%) were healthcare workers. Our results showed that 67.2% of the patients had at least one manifestation related to the oral cavity and salivary glands, and 32.8% ( n = 19) did not have any symptoms associated with the oral cavity. The highest prevalence symptoms were dry mouth 39.7% ( n = 23), gustatory dysfunction as 34.5% (n = 20) loss of salt sensation, 29.3% ( n = 17) loss of sweet sensation, and 25.9% ( n = 15) altered food taste, while the least prevalent symptoms were tongue redness 8.8% ( n = 5), and gingival bleeding 7% ( n = 4). The most frequently associated symptoms were loss of salt and sweetness, as reported by 27.6% of the participants. However, there was no significant association between the incidence of oral symptoms and demographic data (age, gender, or job) of the patients ( p > 0.05). Conclusions Based on limited data, COVID‐19 significantly impacts the oral cavity and salivary glands, as salivary gland‐related symptoms and taste disorders are highly prevalent in COVID‐19 patients.
ObjectiveThis scoping review aims to systematically identify the types, characteristics, and possible pathophysiologic etiologies of the oral ulcers that emerge in COVID-19 patients.IntroductionThe oral cavity is a vulnerable niche for the most diverse microbial ecosystem in the human body; therefore, it presents a wide array of mucocutaneous complications that could indicate various acute and chronic conditions. The COVID-19-related oral conditions, including oral ulcers, had been widely debated as direct manifestations or indirect complications of the SARS-CoV-2 infection. According to a preliminary search of PROSPERO, MEDLINE, the Cochrane Database of Systematic Reviews and the JBI Evidence Synthesis, there is no published nor registered scoping review concerned with the oral ulcers of COVID-19 patients.Inclusion criteriaThe review will include studies included COVID-19 patients whose infection had been confirmed by RT-PCR testing regardless of infection severity and clinical course. Only the studies that reported COVID-19 patients with oral ulcers.MethodsA three-phase search strategy will be carried out: an initial limited search, a full electronic search, and hand search using the reference lists of all included records. The main bibliographic databases of published literature will include MEDLINE (PubMed), Cochrane COVID-19 Study Register, EMBASE via Ovid, and Scopus. All identified records will be managed using EndNote 9.2, and the titles and abstracts will be screened against the inclusion criteria before the full text of all potentially relevant studies will be examined. The data will be presented in tabular form, rating maps, and narrative summary.RegistrationThis protocol had been pre-registered in Open Science Framework (OSF) Registries.[1]
Purpose: to assess the prevalence of temporomandibular disorders among dental undergraduate Egyptian students and the association between the clinical features and radiographic findings. Material and Methods: 281 female dental undergraduate students were randomly selected to participate in the primary screening. In the study screening examination and final diagnosis were done according to a new modified Diagnostic Criteria for TMD (DC/TMD) Axis I which encompass (medical history, primary pain screening questionnaire, signs and symptoms questionnaire and examination protocol). The examination consisted of 11 criteria (pain location, headache location, incisal relationship ,opening pattern ,opening movement ,lateral and protrusive movements ,noises during opening movement ,noises during lateral and protrusive movements, TMJ locking, muscle palpation and TMJ, supplemental muscle pain and palpation, occlusion assessment was added to the criteria Results: the prevalence of TMD was 28.5% among female dental students, the most common reported symptom in a percentage of 89% was pain ,noises were reported in 59.3%f the subjects .The most common subtype of the TMD was muscular pain (mylagia and myofascial pain ) with percentge of 29.2%, 15.4% then arthylagia with 27.7% disc displacement was reported in 13,8 and degenerative reported in 1.5% Conclusions: TMDS is highly prevalent conditions in young population. There is an adequate association between the stress in the university years and the TMDS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.